Company
Headquarters: Stockholm, Sweden
Employees: 418
CEO: Dr. Johan Lof
kr4.72 Billion
SEK as of July 1, 2024
US$445.1 Million
Company | Market Cap (USD) |
---|---|
GE HealthCare | $38.72 B |
Veeva Systems Inc. | $36.20 B |
HealthEquity, Inc. | $9.07 B |
Change Healthcare Inc. | $9.03 B |
Pro Medicus Limited | $8.96 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
RaySearch Laboratories AB has the following listings and related stock indices.
Stock: OMX: RAY.B wb_incandescent
Stock: FSX: 27R wb_incandescent
Stock: OTC: RSLBF wb_incandescent